In the synthesis of certain angiotensin-converting enzyme (ACE) inhibitors possessing a sulfhydryl pharmacophore, the stereodefined (4S)-mercaptoproline core serves as the zinc-binding scaffold. The title compound presents this core with the thiol masked as the free sulfhydryl (after appropriate deprotection) and the carboxylic acid activated or protected as the 4-nitrobenzyl ester. A documented route to zofenoprilat—the active diacid of the prodrug zofenopril—proceeds via condensation of (2S,4S)-4-(phenylthio)proline or related intermediates, but alternative manufacturing strategies have evaluated the use of N-carbamoyl-4-mercaptoproline esters to circumvent the S-phenylthio cleavage step and reduce residual palladium in the final API. Specifically, (2S,4S)-1-pyrrolidinecarboxylic acid, 2-[(dimethylamino)carbonyl]-4-mercapto-, (4-nitrophenyl)methyl ester has been investigated as a late-stage intermediate where the dimethylcarbamoyl group provides transient N-protection compatible with hydrogenolytic removal of the 4-nitrobenzyl ester under conditions that leave the thiol intact when coordinated with a suitable cation. Production-scale hydrogenation in a jacketed stirred-tank reactor (DIN 28136) over 5% Pd/BaSO₄ at 0.3–0.5 MPa H₂ pressure and 25–30°C yields the corresponding free acid, which is subsequently coupled with (S)-3-(benzoylthio)-2-methylpropanoic acid chloride at −5°C to 0°C in dichloromethane, maintaining 99.5% ee as verified by chiral HPLC (USP <621>). Regulatory compliance for the intermediate is governed by ICH Q7 for active pharmaceutical ingredient starting materials, with the final drug substance meeting Ph. Eur. monograph 01/2024:2535 limits for impurity E (S,S,S-isomer) ≤ 0.15%. The recommended molar addition of the intermediate in the coupling step ranges from 1.05 to 1.10 equivalents relative to the acid chloride to drive completion while avoiding excessive thiolate formation that could lead to disulfide dimerization. Typical batch sizes on a production scale employ 25–50 kg of the intermediate per batch, and the end product is compressed into zofenopril calcium tablets (30 mg and 60 mg strengths) compliant with ICH Q3D elemental impurity limits.
How Is the 4-Nitrobenzyl Ester Utilized in Solid-Phase Peptide Synthesis Under Photolabile Linker Protocols?
The 4-nitrobenzyl chromophore exhibits photolytic cleavage at 360 nm, a property exploited in photolabile solid-phase peptide synthesis (SPPS) handles. In this application, the compound is covalently anchored to aminomethyl polystyrene resin (1% DVB, 200–400 mesh) by reacting the free carboxylic acid (after saponification of the methyl ester) with the resin-bound amine using HBTU/DIEA activation. The loading achieved ranges from 0.2 to 0.5 mmol/g depending on resin substitution and coupling time, a level necessary to minimize chain aggregation during subsequent Fmoc-strategy peptide elongation performed on a CS Bio CS336X automated synthesizer. After chain assembly, irradiation at 360 nm in a 1:1 (v/v) mixture of TFE and 50 mM Tris buffer at pH 7.4 releases the peptide with the C-terminal carboxylic acid and the thiol moiety restored. Because the dimethylamino carbonyl group is stable under the acidic cleavage conditions employed for side-chain deprotection (TFA/TIS/H₂O, 95:2.5:2.5), the handle can be used for peptides containing free cysteines without premature disulfide scrambling, provided the photolysis chamber is degassed with argon. Compliance with FDA guidance for peptide drug substances requires control over process-related impurities; residual 4-nitrobenzyl alcohol is monitored by LC-MS to ≤ 10 ppm. The terminal products include linear and cyclic therapeutic peptides such as the thrombopoietin receptor agonist romiplostim precursor fragments, where regioselective disulfide pairing governs biological activity.
Asymmetric Conjugate Addition—A Chiral Ligand Scaffold in Copper-Catalyzed Reactions
The 2-[(dimethylamino)carbonyl] substituent and the 4-mercapto group together form a bidentate N,S-ligand system after selective deprotection of the thiol. Under argon atmosphere, the compound is reacted with LiHMDS (1.0 eq) in THF at −78°C to generate the thiolate, which coordinates to Cu(I) bromide dimethyl sulfide complex to form a chiral copper thiolate catalyst. This catalyst has been evaluated for enantioselective conjugate addition of diethylzinc to cyclic enones; (2S,4S) configuration induces primarily (S) product configuration with enantiomeric ratios up to 92:8 when the ligand-to-copper ratio is maintained at 1.2:1. Batch-mode reactions in a microreactor (Corning Advanced-Flow G1) achieve residence times of 30–120 seconds, outperforming batch-stirred tanks where catalyst degradation occurs above −30°C. The addition level of the ligand precursor relative to substrate stands at 5 mol%, a loading validated by ICH Q2(R1) linearity studies for the quantification of residual metals in the final chiral building blocks (Cu ≤ 25 ppm). The downstream process involves quenching with saturated NH₄Cl, extraction with methyl tert-butyl ether, and purification by fractional distillation under vacuum (0.1 mbar). The resulting enantioenriched ketones serve as intermediates for the synthesis of A₂A adenosine receptor antagonists in Phase II clinical trials.
When the compound is employed as a macromolecular chain transfer agent (macro-CTA) in reversible addition-fragmentation chain transfer (RAFT) polymerization, the thiol functionality is first converted to a thiocarbonylthio moiety by reacting with carbon disulfide and benzyl bromide, while the 4-nitrobenzyl ester remains intact as a photoremovable end-group. In the polymerization of methyl methacrylate initiated with AIBN at 70°C and controlled by this macro-CTA at a [CTA]:[initiator] ratio of 10:1, the molecular weight dispersity (Đ) is narrowed to 1.15 at 60% monomer conversion, as determined by SEC-MALS following ISO 13885:2020. Once polymerization is complete, exposure to 365 nm UV light removes the 4-nitrobenzyl group, liberating a carboxylic acid end-group that can conjugate to amine-functionalized surfaces. This block copolymer construction method has been employed on an Industrie-Biomediche AN-30 twin-screw extruder for melt grafting of polymethylmethacrylate-block-poly (n-butyl acrylate) onto plasma-treated polyurethane catheters, where the additive fraction of the macro-CTA-derived block copolymer is 0.8–1.2 wt% relative to the base polyurethane. The process complies with ISO 10993-5 for in vitro cytotoxicity, with extractables including 4-nitrobenzyl alcohol limited to <0.1 µg/mL. The terminal product is a lubricious, hemocompatible central venous catheter with reduced platelet adhesion confirmed in a Chandler loop model.
Crosslinkable Elastomer Networks Through Sequential Thiol-Isocyanate and Photodeblocking Chemistry
Within cast polyurethane elastomers based on poly(tetramethylene ether) glycol (PTMEG, Mn 2000) and 4,4′-methylenebis(phenyl isocyanate) (MDI), the bifunctional nature of the intermediate—a concealed thiol and a photocleavable ester—enables a two-stage curing process. In the first stage, a fractional amount of the compound (0.05–0.10 molar equivalents relative to total isocyanate groups) is reacted via the in situ deprotected thiol with a portion of the isocyanate termini to form thiourethane linkages, monitored by the disappearance of the NCO band at 2270 cm⁻¹ in FTIR (ASTM D2572-19). This creates a lightly crosslinked network with a gel fraction exceeding 95% after 72 h ambient cure. In the second stage, patterned UV exposure at 365 nm through a quartz photomask selectively removes the 4-nitrobenzyl ester caps, revealing free carboxylic acid groups in irradiated zones. These acids react with a post-added aromatic bis(oxazoline) crosslinker (1,3-phenylene bis(oxazoline)) at 120°C for 30 min, doubling the crosslink density locally (measured by dynamic mechanical analysis as an increase in rubbery plateau modulus from 4.2 MPa to 8.6 MPa). Unreacted bis(oxazoline) and 4-nitrobenzyl alcohol byproducts are extracted with methanol (Soxhlet, 16 h), keeping extractables below 0.5% by mass per ISO 6427. The final product is a microstructured elastomeric stamp for microcontact printing used in the fabrication of organic thin-film transistor arrays, where differential modulus across the stamp surface controls ink transfer uniformity.
| Parameter | Condition A (pH 5.5) | Condition B (pH 7.4) | Reporting Limit |
|---|---|---|---|
| kphotolysis (360 nm) | 0.12 min⁻¹ ±0.02 | 0.09 min⁻¹ ±0.01 | — |
| 4-Nitrobenzyl alcohol (µg/L) | <50 | <50 | 10 |
| Proline-acid byproduct (µg/L) | <100 | <200 | 20 |
| Dimethylamine (µg/L) | ≤0.5 | ≤0.4 | 0.1 (IC) |
Where the compound is supplied as a pre-blended additive concentrate in a thermoplastic polyurethane (TPU) masterbatch for radiopaque medical tubing, the incorporation ratio is 2.0–3.5 phr let down into a base TPU (Shore 80A) on a single-screw extruder (L/D 24:1, compression ratio 2.5:1). During extrusion at 190–210°C, the thiol group reacts with residual isocyanate from the TPU backbone, generating non-migrating thiourethane crosslinks that increase the vicat softening temperature by 8–12°C (ISO 306:2022 method A50). A subsequent electron-beam sterilization step at 25 kGy partially reduces the 4-nitrobenzyl ester to a hydroxamic acid derivative, detectable as a low-intensity peak in the HPLC fingerprint. The product complies with USP Class VI biological reactivity testing; limits for dimethylamine extractables are set at < 5 µg/cm² per ISO 10993-12:2021.
Mitigation of Hydrogen Sulfide Release During Latex Film Vulcanization of Natural Rubber Gloves
Natural rubber latex compounds crosslinked with conventional sulfur/accelerator systems generate volatile hydrogen sulfide as a byproduct of dithiocarbamate degradation during post-vulcanization leaching. Incorporating the title compound at 0.15–0.25 wt% (dry rubber content) as a reactive thiol donor, pre-dispersed in a 10% aqueous sodium dodecyl sulfate solution and added to the compounded latex at the maturation stage ( 24 h at 25°C under continuous stirring), results in the covalent binding of the mercapto group to unsaturated isoprene units via thiol-ene addition during the vulcanization step at 120°C for 20 min. Headspace gas chromatography of the vulcanizate (ASTM D5504-20) shows a reduction in H₂S concentration from 12.7 ppm to 1.8 ppm. The 4-nitrobenzyl ester moiety hydrolyzes partially in the alkaline latex environment (pH 10.2), generating 4-nitrobenzyl alcohol, which is removed during the leaching cycle ( 60 min in running deionized water at 60°C). Residual concentrations of 4-nitrobenzyl alcohol in the finished glove are controlled to ≤ 0.5 µg/g (EN 455-3:2024 extraction conditions). The end-product is a powder-free examination glove conforming to ASTM D3578-19, exhibiting tensile strength of 24 MPa and elongation at break 850% after aging at 70°C for 7 days. Critical limitation: ammonia-preserved natural latex must be de-ammoniated to 0.15% or lower before addition to avoid premature degradation of the dimethylcarbamoyl protecting group.
